Managing treatment resistance in schizophrenia: a joint study in Hong Kong and Singapore

Managing treatment resistance in schizophrenia: a joint study in Hong Kong and Singapore

This study surveyed clinicians in psychiatry in Hong Kong and Singapore to understand their familiarity and prescribing practices in treatment-resistant schizophrenia (TRS) and clozapine-resistant schizophrenia (CRS).

Detalhes bibliográficos
Main Authors:	Zheng, Shushan, Chan, Sherry Kit Wa, Lee, Jimmy
Outros Autores:	Lee Kong Chian School of Medicine (LKCMedicine)
Formato:	Journal Article
Idioma:	English
Publicado em:	2023
Assuntos:	Science::Medicine Clozapine Treatment Resistance
Acesso em linha:	https://hdl.handle.net/10356/171024

Registos relacionados

Association between treatment resistance and cognitive function in schizophrenia
Por: Jiaqian Sun, et al.
Publicado em: (2024-10-01)

Successful utilization of clozapine for a patient with treatment‐resistant schizophrenia after recurrent violent behavior
Por: Rikuto Christopher Shinohara, et al.
Publicado em: (2024-09-01)

Delay in Clozapine Initiation in Patients with Treatment-Resistance Schizophrenia Presenting Tertiary Psychiatric Facilities
Por: Asad Ullah Jan, et al.
Publicado em: (2024-06-01)

Disability and quality of life in patients with treatment-resistant schizophrenia on long- term clozapine therapy
Por: Dhandapani Nandakumar, et al.
Publicado em: (2023-06-01)

Antipsychotic polypharmacy in clozapine resistant schizophrenia: a randomized controlled trial of tapering antipsychotic co-treatment
Por: Jari Tiihonen, et al.
Publicado em: (2012-01-01)

Clozapine combination and augmentation strategies in patients with schizophrenia - recommendations from an international expert survey among the treatment response and resistance in psychosis (TRRIP) working group
Por: Wagner, Elias, et al.
Publicado em: (2021)

Protocol for Cancloz: multicentre randomised, placebo-controlled, double-blind, parallel-group adaptive trial of cannabidiol for clozapine-resistant schizophrenia
Por: Dan Siskind, et al.
Publicado em: (2024-09-01)

Combination of Two Long-Acting Antipsychotics in Schizophrenia Spectrum Disorders: A Systematic Review
Por: Salvatore Cipolla, et al.
Publicado em: (2024-04-01)

Efficacy of clozapine in patients with schizophrenia – A 3-month follow-up study from North India
Por: Paramvir Singh, et al.
Publicado em: (2023-01-01)

Combined use of antipsychotics and electroconvulsive therapy in theurapetically resistant schizophrenia
Por: S. V. Sizov, et al.
Publicado em: (2018-07-01)

The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force
Por: Hélène Verdoux, et al.
Publicado em: (2025-01-01)

Knowledge domain and trends in treatment-resistant schizophrenia (TRS) research based on CiteSpace bibliometrics analysis
Por: Haipeng Cai, et al.
Publicado em: (2024-11-01)

Clozapine use for bipolar disorder: an Asian psychotropic prescription patterns consortium study
Por: Loo, Javier Lek Wei, et al.
Publicado em: (2023)

Cariprazine and clozapine combination for the treatment of psychosis in a young, female patient with schizophrenia: a case report
Por: Anzejs Dmuhovskis, et al.
Publicado em: (2024-08-01)

Dysfunction of the NMDA Receptor in the Pathophysiology of Schizophrenia and/or the Pathomechanisms of Treatment-Resistant Schizophrenia
Por: Ruri Okubo, et al.
Publicado em: (2024-09-01)

Dropout rates and reasons for dropout among patients receiving clozapine
Por: Sandeep Grover, et al.
Publicado em: (2023-06-01)

The effects of clinical and pharmacological factors on the ratio of clozapine to norclozapine in psychiatric patients
Por: Anna Mach, et al.
Publicado em: (2025-01-01)

The effect of clozapine on immune-related biomarkers in schizophrenia patients
Por: Lu Shao, et al.
Publicado em: (2024-11-01)

Arrhythmia induced by clozapine in patients with schizophrenia： a Meta-analysis
Por: Chen Yadi, et al.
Publicado em: (2024-10-01)

A Synthetic Literature Review on the Management of Emerging Treatment Resistance in First Episode Psychosis: Can We Move towards Precision Intervention and Individualised Care?
Por: Siân Lowri Griffiths, et al.
Publicado em: (2020-11-01)

The Use of Ascorbic Acid in Adjunctive Treatment for Schizophrenia—Current State of Knowledge
Por: Patrycja Piłat, et al.
Publicado em: (2024-06-01)

Effective and underprescribed: what about clozapine?
Por: Helge H.O. Müller
Publicado em: (2017-10-01)

Association of clozapine with structural and resting-state functional abnormalities of the hippocampus in chronic schizophrenia
Por: Sung Woo Joo, et al.
Publicado em: (2024-10-01)

Prevalence of obsessive-compulsive symptoms in patients with schizophrenia treated with clozapine: a scoping review
Por: Evelyn Moreno Tarazona, et al.
Publicado em: (2025-01-01)

Efficacy of clozapine versus standard treatment in adult individuals with intellectual disability and treatment-resistant psychosis (CLOZAID): study protocol of a multicenter randomized clinical trial
Por: María Alemany-Navarro, et al.
Publicado em: (2024-05-01)

Successful Management of Acute Anti psychotic Poisoning Induced Multi-Organs Toxicities -A Case Report and Review of Literature
Por: Manal Hassan, et al.
Publicado em: (2024-03-01)

Treatment of a schizophrenia patient on long-term super-dose antipsychotics: a case report
Por: Xiaobo Xie, et al.
Publicado em: (2025-01-01)

History of suicidal behavior and clozapine prescribing among people with schizophrenia in China: a cohort study
Por: Yi Yin, et al.
Publicado em: (2024-06-01)

Predictors of functioning in treatment-resistant schizophrenia: the role of negative symptoms and neurocognition
Por: Li, Yanhui, et al.
Publicado em: (2024)

Prevalence and factors associated with high risk for obstructive sleep apnea in schizophrenia spectrum disorder patients on long-term clozapine
Por: Rika Rijal, et al.
Publicado em: (2024-12-01)

Optimal Treatment of Magnetic Seizure Therapy (MST) in Patients with Clozapine-Resistant Schizophrenia (CRS)
Por: Xiang Q, et al.
Publicado em: (2025-03-01)

Effects of Antipsychotics on the Hypothalamus–Pituitary–Adrenal Axis in a Phencyclidine Animal Model of Schizophrenia
Por: Tatjana Nikolić, et al.
Publicado em: (2024-08-01)

Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety
Por: De las Cuevas C, et al.
Publicado em: (2024-11-01)

Clozapine-induced hypertension: A paradox
Por: Hamza Hussain, et al.
Publicado em: (2024-12-01)

Clozapine Withdrawal Catatonia: A Case Series and Review of Literature
Por: Gopika Jagota, et al.
Publicado em: (2024-06-01)

Specific features of psychopathological manifestations in criminal clozapine intoxications
Por: D. G. Slyundin, et al.
Publicado em: (2010-09-01)

A cross-sectional study to analyze the pattern of pharmacotherapy and its associated factors among patients with schizophrenia
Por: B. S. Abhishree, et al.
Publicado em: (2024-12-01)

Comparative effectiveness of clozapine and non-clozapine atypical antipsychotics provided by the Brazilian National Health System in adults with schizophrenia
Por: Júlio César Menezes Vieira, et al.
Publicado em: (2024-06-01)

Children’s everyday lifeworlds out of school, in Hong Kong, Melbourne, and Singapore: Family, enrichment activities, and local communities
Por: Nicola Yelland, et al.
Publicado em: (2024-07-01)

Dose-dependent clozapine-induced skin picking and self-injurious behaviour in treatment-resistant schizophrenia
Por: Layani C. Rathnayake, et al.
Publicado em: (2020-06-01)